Видео ютуба по тегу David Avigan

FAQs on Clinical Trials: What Every Patient Should Know
FAQs on Clinical Trials: What Every Patient Should Know
Noninferiority of Denosumab As Compared With Zolendronic Acid With Respect to the Ability to Dela...
Noninferiority of Denosumab As Compared With Zolendronic Acid With Respect to the Ability to Dela...
Myeloma Crowd Radio: Dr. David Avigan, MD, Beth Israel Deaconess Medical Center
Myeloma Crowd Radio: Dr. David Avigan, MD, Beth Israel Deaconess Medical Center
MMRF 25 Voices - Dr. David Avigan
MMRF 25 Voices - Dr. David Avigan
Laboratory Assessment of Immune Functioning | Doctors Avigan and Ludwig | IMS 2023
Laboratory Assessment of Immune Functioning | Doctors Avigan and Ludwig | IMS 2023
The role of vaccines in AML
The role of vaccines in AML
Impact of dendritic cell fusion vaccine on the microenvironment and outcomes in multiple myeloma
Impact of dendritic cell fusion vaccine on the microenvironment and outcomes in multiple myeloma
Immune dysregulation in myeloma and impact on disease progression
Immune dysregulation in myeloma and impact on disease progression
Cellular Immunotherapy for the Treatment of Multiple Myeloma
Cellular Immunotherapy for the Treatment of Multiple Myeloma
Vaccines and immunotherapy in hematological malignancies
Vaccines and immunotherapy in hematological malignancies
CAR-T: hurdles and ladders
CAR-T: hurdles and ladders
Dr. Avigan on CAR T-Cell Therapy in Lymphoproliferative Disease
Dr. Avigan on CAR T-Cell Therapy in Lymphoproliferative Disease
AML: Vaccination, hypomethylation and CAR-T
AML: Vaccination, hypomethylation and CAR-T
AML: hybridoma vaccines
AML: hybridoma vaccines
Immunotherapeutic approaches to myeloma
Immunotherapeutic approaches to myeloma
Investigating vaccines for hem-onc: key questions
Investigating vaccines for hem-onc: key questions
Dendritic cell vaccine for MM: Trial updates with maintenance & checkpoint inhibitor pidilizumab
Dendritic cell vaccine for MM: Trial updates with maintenance & checkpoint inhibitor pidilizumab
Personalized dendritic cell vaccine for acute leukemia and multiple myeloma
Personalized dendritic cell vaccine for acute leukemia and multiple myeloma
David Avigan on Precision Immuno
David Avigan on Precision Immuno
MMRF Immunotherapy Kick-Off: David Avigan
MMRF Immunotherapy Kick-Off: David Avigan
Utilizing combination therapies for multiple myeloma
Utilizing combination therapies for multiple myeloma
Dendritic cell vaccine for MM: progress so far
Dendritic cell vaccine for MM: progress so far
David E. Avigan, MD, Immune Therapy and Immunology
David E. Avigan, MD, Immune Therapy and Immunology
Message from Dr David Avigan
Message from Dr David Avigan
How can a patient be proactive in their care and treatment?
How can a patient be proactive in their care and treatment?